Impact of simulation via instant messaging -birmingham advance (SIMBA) on clinician

Pavithra Sakthivel; Anisah Ali; Sangamithra Ravi; Rachel Shepherd; Abby Radcliffe; Rahul Sagu; Balakrishnan Harshin Pallathoor; Sumaya Najeem; Neelamabraprasad Goznee; Vyshnavi ND; Tamzin Ogiliev; Punith Kempegowda; Comics Team Simba &

doi:10.1530/endoabs.99.P466

P466

Prev Next

Section Contents Cite

Endocrine Abstracts (2024) 99 P466 | DOI: 10.1530/endoabs.99.P466

ECE2024 Poster Presentations Diabetes, Obesity, Metabolism and Nutrition (130 abstracts)

Impact of simulation via instant messaging –birmingham advance (SIMBA) on clinician’s confidence to manage type 1 diabetes mellitus using technological advances in endocrinology

Pavithra Sakthivel ¹ , Anisah Ali ¹ , Sangamithra Ravi ¹ , Rachel Shepherd ¹ , Abby Radcliffe ¹ , Rahul Sagu ¹ , Harshin Pallathoor Balakrishnan ² , Sumaya Najeem ² , Neelamabraprasad Goznee ² , Vyshnavi ND ² , Tamzin Ogiliev ³ , Punith Kempegowda ^4,5 & Simba

View

Author affiliations

¹University of Birmingham, College of Medical and Dental Sciences, Birmingham, United Kingdom; ²Far Eastern Federal University, School of Medicine, Vladivostok, Russian Federation; ³Lancaster University Medical School, Lancatser, United Kingdom; ⁴University of Birmingham, Institute of Metabolism and Systems Research, Birmingham, United Kingdom; ⁵University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom

Introduction: Various technological advances have infiltrated modern clinical practice. This is especially true for the management of type 1 diabetes mellitus (T1DM). User-friendly and convenient smartphone applications like Dexcom and Freestyle Libre have positively contributed towards the control and monitoring of diabetes for patients across the globe. Simulation via Instant Messaging –Birmingham Advance (SIMBA) conducted a virtual training session for clinicians in managing T1DM using these systems.

Aim: To improve healthcare professionals’ (HCPs) knowledge and confidence in managing patients with T1DM using technological advances.

Methods: Anonymised case transcripts were created based on real-life clinical scenarios involving the management of T1DM using Freestyle Libre and Dexcom G6. They were used to train moderators, who then virtually simulated these cases with participants via WhatsApp. Clinicians’ approach to each case was scored by moderators using a modified global rating scale to consider aspects including interpretation of relevant investigations and proposing an appropriate management plan. The simulation was followed by a discussion session led by a topic expert, delving into the key learning points from each case. Participants completed pre- and post-simulation surveys. Quantitative and thematic analysis of HCPs’ perspectives and experience of the session was conducted.

Results: A total of 21 HCPs participated in the session, 95.2% of whom were based in the United Kingdom. Participants’ self-reported confidence in using Freestyle Libre and Dexcom G6 improved from 66.7% and 33.3% to 90.5% (P=0.0143) and 76.2% (P=0.0009), respectively, following the simulation. 95.2% of participants agreed that the simulated topics applied to their clinical practice and reported that the simulation training had a positive influence on their knowledge of patient management and care provision. HCPs also believed the session improved their professionalism (52.4%), practice-based learning (76.1%) and communication skills (23.8%). Additionally, the simulation was considered impactful on a personal and professional level by 81% and 76.2%. Thematic analysis revealed that participants were more confident in offering continuous glucose monitoring (CGM) to their patients and interpreting data produced by CGM applications. Participants also gained awareness of non-medical aspects, such as the availability of educational programmes surrounding the use of technology to empower patients with T1DM.

Conclusion: SIMBA is an evidence-based educational programme that has improved HCPs’ knowledge of utilising technological advancements in the management of patients with T1DM, thereby encouraging them to offer these tools to more patients and lead to better outcomes.